Open AccessOptimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine
Author(s) -
Eunyoung Lee,
June Young Chun,
Kyoung Ho Song,
Pyoeng Gyun Choe,
Ji Hwan Bang,
Eu Suk Kim,
Hong Bin Kim,
Sang-Won Park,
Nam Joong Kim,
Myoung Don Oh
Publication year - 2018
Publication title -
infection and chemotherapy/gam'yeom gwa hwahag yo'beob/infection and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.724
H-Index - 26
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2018.50.4.311
Subject(s) - medicine , shingles , immunogenicity , vaccination , elispot , varicella zoster virus , immunology , prospective cohort study , virus , immune system , t cell
Zoster vaccination is recommended for people with a history of herpes zoster (HZ), but the most effective timing of vaccine administration after zoster illness is unresolved. This prospective observational study compared the immunogenicity and safety of administering HZ vaccine at 6-12 months and 1-5 years after zoster illness.